 |
市場調查報告書
商品編碼
1149871
兒科臨床試驗市場：按臨床試驗階段、研究設計、疾病狀況、地區 - 規模、份額、展望、機會分析，2022-2030 年Pediatric Clinical Trials Market, by Clinical Trial Phase, by Study Design, by Medical Condition, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 |
||||||
價格
簡介目錄
兒科臨床試驗在現代醫療保健中發揮著重要作用，作為針對影響兒科人群的各種適應症將新藥推向市場的單一標準。兒科臨床試驗對於開發適合年齡的、經過經驗驗證的治療和乾預措施以及確定和改善現有的最佳醫療服務至關重要。
臨床開發中有許多產品管線可以滿足兒科患者未滿足的醫療需求。兒科臨床試驗可以幫助確定兒童藥物和疫苗的理想劑量，還可以專注於創造易於吞嚥的液體製劑。兒科臨床試驗有助於開發對兒童安全有效的藥物和免疫接種。兒科臨床試驗可以幫助開發適合兒童劑量的藥物和疫苗，並可以專注於開發更易於吞嚥的液體製劑。兒童參與臨床試驗有助於為兒童開發安全有效的藥物和疫苗。
市場動態
對預防麻疹、腮腺炎、脊髓灰質炎、肺結核、風疹、流感、百日咳、水痘、瘧疾和鏈球菌性咽喉炎等各種傳染病的新疫苗和其他生物製劑的需求不斷增加，正在推動市場。預計將帶動的增長例如，根據國際糖尿病聯合會 (IDF) 糖尿病地圖集 2020，2019 年全球將有約 4.63 億人患有糖尿病。其中，100 萬（20 歲以下的兒童和青少年）患有 1 型糖尿病。
這項研究的主要特點
- 本報告對全球兒科臨床試驗市場進行了深入分析，闡明了以 2021 年為基準年的預測期（2022-2030 年）內市場規模和復合年增長率 (CAGR%) 的增長。
- 解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
- 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
- 根據公司亮點、產品組合、主要亮點、財務業績和戰略等參數，對全球兒科臨床試驗市場的主要參與者進行概況分析。
- 本研究涵蓋的主要公司包括 Syneos Health Inc.、IQVIA Holdings, Inc.、Charles River Laboratories International Inc.、Covance Inc.、ICON plc、Pharmaceutical Product Development, LLC、Genentech (F. Hoffmann-La Roche AG)、Pfizer, Inc.、Bristol-Myers Squibb、GlaxoSmithKline plc.、Sanofi S.A.、Novartis AG、強生、默克公司、Takeda Pharmaceutical Company Limited 和 Vertex Pharmaceuticals Inc.。
- 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
- 《全球兒科臨床試驗市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
- 利益相關者可以通過用於分析全球兒科臨床試驗市場的各種戰略矩陣來促進決策制定。
內容
第 1 章目的和先決條件
- 調查目的
- 先決條件
- 縮寫說明
第二章市場展望
- 報告內容
- 市場定義和範圍
- 執行摘要
- 市場概況：按臨床試驗階段
- 研究設計的市場概況
- 市場概況：按醫療條件
- 市場概況：按地區
- 連貫機會圖 (COM)
第3章市場動態、規律及趨勢分析
- 市場動態
- 司機
- 約束因素
- 市場機會
- 影響分析
- 市場趨勢
- 近期趨勢
- 收購和合作場景
- 技術概覽
- 監管情景
- 管道分析
- 害蟲分析
第 4 章全球兒科臨床試驗市場：冠狀病毒 (COVID-19) 大流行的影響
- 總體影響
- 對供需的影響
- COVID-19 對市場的影響
第 5 章全球兒科臨床試驗市場：按臨床試驗階段，2017-2030
- 臨床前研究
- 第一階段
- 第二階段
- 第三階段
第 6 章全球兒科臨床試驗市場：按研究設計，2017-2030
- 治療研究
- 觀察性研究
第 7 章全球兒科臨床試驗市場：按條件，2017-2030
- 神經精神系統疾病
- 感染
- 孕產婦和圍產期疾病
- 呼吸系統疾病
- 心血管疾病
- 癌症
- 消化系統疾病
- 其他
第 8 章全球兒科臨床試驗市場：按地區劃分，2017-2030
- 北美
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲地區
- 歐洲
- 英國
- 德國
- 意大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲地區
- 亞太地區
- 中國
- 印度
- 日本
- 東盟
- 澳大利亞
- 韓國
- 其他亞太地區
- 中東
- 海灣合作委員會
- 以色列
- 其他中東地區
- 非洲
- 北非
- 中非
- 南非
第9章競爭格局
- Syneos Health Inc
- IQVIA Holdings, Inc.
- Charles River Laboratories International Inc
- Covance Inc
- ICON plc
- Pharmaceutical Product Development, LLC
- Genentech（F. Hoffmann-La Roche AG
- Pfizer, Inc
- Bristol-Myers Squibb
- GlaxoSmithKline plc
- Sanofi S.A
- Novartis AG
- Johnson & Johnson
- Merck & Co., Inc
- Takeda Pharmaceutical Company Limited
- Vertex Pharmaceuticals Inc.
第 10 章
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI397
Pediatric clinical trials play a major role in modern healthcare, as pediatric clinical trials are the only criteria to launch new drugs in market for various indications that affect pediatric population. Clinical trials in children are essential to develop age-specific, empirically-verified therapies and interventions to determine and improve the best medical treatment available.
There is significant product pipeline under clinical stage of development due to unmet medical needs for pediatric patient population. A pediatric clinical trial could assist in determining the ideal dosage of a medication or vaccine for a child, or it could concentrate on creating an easier-to-swallow liquid formulation. Clinical trials involving children aid in the development of child-safe and -effective medications and vaccinations. A pediatric clinical trial could help develop the correct dose of a medicine or vaccine for a child, or it could focus on development of a liquid formulation that is easier to swallow. Participation from children in clinical trials helps develop medicines and vaccines that are safe and effective for children.
Market Dynamics
Increasing demand for new vaccines and other biologic products to prevent various infectious diseases such as measles, mumps, polio, tuberculosis, rubella, influenza, whooping cough, chickenpox, malaria, and streptococcal pharyngitis is expected to drive the market growth. For instance, according to the International Diabetes Federation's (IDF) Diabetes Atlas 2020, around 463 million patients were suffering from diabetes worldwide in 2019. Of this, one million people (children and adolescents below 20 years of age) were suffering from type 1 diabetes.
Key features of the study:
- This report provides in-depth analysis of the global pediatric clinical trials market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pediatric clinical trials market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Syneos Health Inc., IQVIA Holdings, Inc., Charles River Laboratories International Inc., Covance Inc., ICON plc, Pharmaceutical Product Development, LLC, Genentech (F. Hoffmann-La Roche AG), Pfizer, Inc., Bristol - Myers Squibb, GlaxoSmithKline plc., Sanofi S.A., Novartis AG, Johnson & Johnson, Merck & Co., Inc., Takeda Pharmaceutical Company Limited, and Vertex Pharmaceuticals Inc
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pediatric clinical trials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric clinical trials market
Detailed Segmentation:
- Global Pediatric Clinical Trials Market, By Clinical Trial Phase :
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Global Pediatric Clinical Trials Market, By Study Design:
- Treatment Studies
- Observational Studies
- Global Pediatric Clinical Trials Market, By Medical Condition:
- Neuropsychiatric Conditions
- Infectious Diseases,
- Maternal and Perinatal Conditions,
- Respiratory Diseases,
- Cardiovascular Diseases
- Cancer
- Digestive
- Others
- Global Pediatric Clinical Trials Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Syneos Health Inc
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- IQVIA Holdings, Inc.,
- Charles River Laboratories International Inc.
- Covance Inc.,
- ICON plc,
- Pharmaceutical Product Development, LLC,
- Genentech (F. Hoffmann-La Roche AG),
- Pfizer, Inc.,
- Bristol - Myers Squibb,
- GlaxoSmithKline plc.,
- Sanofi S.A.,
- Novartis AG,
- Johnson & Johnson,
- Merck & Co., Inc.,
- Takeda Pharmaceutical Company Limited,
- Vertex Pharmaceuticals Inc
- Syneos Health Inc
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Clinical Trial Phase
- Market Snapshot, By Study Design
- Market Snapshot, By Medical Condition
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pipeline Analysis
- PEST Analysis
4. Global Pediatric Clinical Trials Market- Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact
- Impact on Supply and Demand
- COVID-19 Impact on the market
5. Global Pediatric Clinical Trials Market, By Clinical Trial Phase , 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Pre-clinical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Phase I
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Phase II
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Phase III
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
6. Global Pediatric Clinical Trials Market, By Study Design , 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Treatment Studies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Observational
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
7. Global Pediatric Clinical Trials Market, By Medical Condition, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Neuropsychiatric Conditions,
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Maternal and Perinatal Conditions
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Respiratory Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Cardiovascular Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Digestive Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
8. Global Pediatric Clinical Trials Market, By Region, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Study Design, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Condition, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Study Design, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Condition, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Study Design, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Condition, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Study Design, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Condition, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Study Design, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Condition, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phase, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Study Design, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Medical Condition, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Syneos Health Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- IQVIA Holdings, Inc.
- Charles River Laboratories International Inc
- Covance Inc
- ICON plc
- Pharmaceutical Product Development, LLC
- Genentech (F. Hoffmann-La Roche AG
- Pfizer, Inc
- Bristol - Myers Squibb
- GlaxoSmithKline plc
- Sanofi S.A
- Novartis AG
- Johnson & Johnson
- Merck & Co., Inc
- Takeda Pharmaceutical Company Limited
- Vertex Pharmaceuticals Inc.
10. Section
- Research Methodology
- About Us
